Innovative Imaging Method to Revolutionize Microscopy
By LabMedica International staff writers Posted on 02 Aug 2024 |

Currently, scanning transmission electron microscopes (STEMs) employ a highly focused electron beam that traverses a sample, creating images point by point. Traditionally, at each point, the beam pauses for a constant, predetermined duration to gather signals, akin to how cameras with photographic film function, resulting in uniformly exposed images across all areas. This method continuously exposes the sample to electrons until the set "dwell-time" for each pixel elapses. Although simple to implement, this technique can subject the sample to excessive radiation, potentially altering or destroying it. Now, a pioneering imaging technique utilizing advanced microscopes has significantly reduced the time and radiation needed for imaging. This advancement is particularly beneficial for fields like medicine, where it promises enhanced imaging of sensitive materials, such as biological tissues, which are highly susceptible to damage.
The new method, devised by an international research group led by Trinity College Dublin (Dublin, Ireland), fundamentally rethinks the traditional imaging process. Rather than measuring the number of detected "events" – electrons scattered from various parts of the sample – over a fixed period, this innovative approach employs an event-based detection system that records the time it takes to detect a predetermined number of events. Both methods provide comparable "detection rate" image contrast, but the novel mathematical theory introduced by the team reveals that while the first electron detected at each position offers substantial information for image construction, additional electrons contribute increasingly less information. Importantly, every electron interacting with the specimen carries a similar risk of damage.
This method enables shutting off the illumination precisely when imaging efficiency becomes optimal, thus requiring fewer electrons to produce an image of equal or superior quality. However, the theory alone does not reduce radiation exposure. To implement this reduced radiation mode, the team has patented a system called Tempo STEM, which integrates a high-tech "beam blanker" that can quickly shut off the beam after achieving the desired accuracy at each sample point. This innovative combination of two cutting-edge technologies marks a significant advancement in microscopy capabilities. By enabling the electron beam to be rapidly turned on and off in response to real-time events, a capability not previously available, this approach not only reduces the overall radiation dose needed for high-quality images but also minimizes unnecessary radiation that offers diminishing returns, thereby protecting the sample from potential damage.
“We tend to think of electrons as relatively mild from a radiation perspective, but when they are fired at a tiny biological sample at speeds of around 75% the speed of light, it’s no surprise that they damage these samples,” said Dr. Jon Peters, Trinity, first author of the research published in the leading international journal Science. “This has been a major issue for microscopy, as the images you get back could be unusable, or worse, misleading. This is obviously problematic if you need to make decisions on future battery materials or catalyst development.”
Related Links:
Trinity College Dublin
Latest Pathology News
- AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care
- AI Tool Enhances Interpretation of Tissue Samples by Pathologists
- AI-Assisted Technique Tracks Cells Damaged from Injury, Aging and Disease
- Novel Fluorescent Probe Shows Potential in Precision Cancer Diagnostics and Fluorescence-Guided Surgery
- New Lab Model to Help Find Treatments for Aggressive Blood Cancer
- AI-Supported Microscopy Improves Detection of Intestinal Parasite Infections
- AI Performs Virtual Tissue Staining at Super-Resolution
- AI-Driven Preliminary Testing for Pancreatic Cancer Enhances Prognosis
- Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response
- Clinical AI Solution for Automatic Breast Cancer Grading Improves Diagnostic Accuracy
- Saliva-Based Testing to Enable Early Detection of Cancer, Heart Disease or Parkinson’s
- Advances in Monkeypox Virus Diagnostics to Improve Management of Future Outbreaks
- Nanoneedle-Studded Patch Could Eliminate Painful and Invasive Biopsies
- AI Cancer Classification Tool to Drive Targeted Treatments
- AI-Powered Imaging Enables Faster Lung Disease Treatment
- New Laboratory Method Speeds Diagnosis of Rare Genetic Disease
Channels
Clinical Chemistry
view channel
New Clinical Chemistry Analyzer Designed to Meet Growing Demands of Modern Labs
A new clinical chemistry analyzer is designed to provide outstanding performance and maximum efficiency, without compromising affordability, to meet the growing demands of modern laboratories.... Read more
New Reference Measurement Procedure Standardizes Nucleic Acid Amplification Test Results
Nucleic acid amplification tests (NAATs) play a key role in diagnosing a wide range of infectious diseases. These tests are generally known for their high sensitivity and specificity, and they can be developed... Read moreMolecular Diagnostics
view channel
DNA Methylation Signatures of Aging Could Help Assess Mortality Risk
Aging is associated with the progressive degeneration and loss of function across multiple physiological systems. Chronological age is the most common indicator of aging; however, there is significant... Read more
Molecular Diagnostics System Provides Lab-Quality Results at POC
Currently, there is a need for a comprehensive molecular diagnostics ecosystem that enables effective diagnostic stewardship, providing the diagnostic tools to offer the right tests, for the right patient,... Read moreHematology
view channel
Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results
Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more
First Point-of-Care Heparin Monitoring Test Provides Results in Under 15 Minutes
Heparin dosing requires careful management to avoid both bleeding and clotting complications. In high-risk situations like extracorporeal membrane oxygenation (ECMO), mortality rates can reach about 50%,... Read moreImmunology
view channel
Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer
Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more
Groundbreaking Lateral Flow Test Quantifies Nucleosomes in Whole Venous Blood in Minutes
Diagnosing immune disruptions quickly and accurately is crucial in conditions such as sepsis, where timely intervention is critical for patient survival. Traditional testing methods can be slow, expensive,... Read moreMicrobiology
view channel
Viral Load Tests Can Help Predict Mpox Severity
Mpox is a viral infection that causes flu-like symptoms and a characteristic rash, which evolves significantly over time and varies between patients. The disease spreads mainly through direct contact with... Read more
Gut Microbiota Analysis Enables Early and Non-Invasive Detection of Gestational Diabetes
Gestational diabetes mellitus is a common metabolic disorder marked by abnormal glucose metabolism during pregnancy, typically emerging in the mid to late stages. It significantly heightens the risk of... Read moreTechnology
view channel
Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation
Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Ultra-Sensitive Biosensor Based on Light and AI Enables Early Cancer Diagnosis
Cancer diagnosis is often delayed due to the difficulty in detecting early-stage cancer markers. In particular, the concentration of methylated DNA in the bloodstream during the early stages of cancer... Read moreIndustry
view channel
Quanterix Completes Acquisition of Akoya Biosciences
Quanterix Corporation (Billerica, MA, USA) has completed its previously announced acquisition of Akoya Biosciences (Marlborough, MA, USA), paving the way for the creation of the first integrated solution... Read more
Lunit and Microsoft Collaborate to Advance AI-Driven Cancer Diagnosis
Lunit (Seoul, South Korea) and Microsoft (Redmond, WA, USA) have entered into a collaboration to accelerate the delivery of artificial intelligence (AI)-powered healthcare solutions. In conjunction with... Read more